Published in Eur Arch Psychiatry Clin Neurosci on January 01, 1994
Dopaminergic signaling and striatal neurodegeneration in Huntington's disease. J Neurosci (2007) 1.44
Functional imaging in Huntington's disease. Exp Neurol (2009) 1.08
Tetrabenazine is neuroprotective in Huntington's disease mice. Mol Neurodegener (2010) 0.93
Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry (1997) 0.89
In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease. Front Syst Neurosci (2011) 0.88
Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report. Rev Colomb Psiquiatr (2008) 0.79
Current status of PET imaging in Huntington's disease. Eur J Nucl Med Mol Imaging (2016) 0.78
Neuroimaging in Huntington's disease. World J Radiol (2014) 0.78
Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI. Eur Arch Psychiatry Clin Neurosci (1997) 0.75
Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT. J Neurol Neurosurg Psychiatry (2001) 0.75
Molecular Imaging Markers to Track Huntington's Disease Pathology. Front Neurol (2017) 0.75
Detection of bacteriuria by luciferase assay of adenosine triphosphate. J Clin Microbiol (1975) 7.06
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44
Comparison of methods for extraction of bacterial adenine nucleotides determined by firefly assay. Appl Microbiol (1975) 3.18
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry (1999) 2.90
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry (1992) 2.84
The predictive validity of body mass index based on self-reported weight and height. Int J Obes (1989) 2.65
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature (1997) 2.46
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology (2009) 2.23
A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature (1990) 2.20
Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry (2000) 2.12
Analytical information obtainable by evaluation of the time course of firefly bioluminescence in the assay of ATP. Anal Biochem (1975) 2.11
Chemical brain anatomy in schizophrenia. Lancet (1995) 2.08
Meiotic drive at the myotonic dystrophy locus? Nat Genet (1994) 2.08
Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99
Comparison of genetic divergence and fitness between two subclones of Helicobacter pylori. Infect Immun (2001) 1.98
Continous monitoring of ATP-converting reactions by purified firefly luciferase. Anal Biochem (1976) 1.93
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum (1994) 1.83
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry (1995) 1.80
Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am J Hum Genet (1994) 1.79
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging (2006) 1.79
Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program. Muscle Nerve (1986) 1.79
Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications. Clin Pharmacol Ther (2009) 1.77
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res (1981) 1.72
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol Aging (2000) 1.71
Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis. J Cereb Blood Flow Metab (1989) 1.71
Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (1986) 1.70
No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone. Psychiatry Res (1995) 1.66
Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem (2001) 1.64
Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab (2000) 1.56
Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum Mol Genet (1993) 1.55
Postoperative pain relief after total hip arthroplasty: a randomized, double-blind comparison between intrathecal morphine and local infiltration analgesia. Br J Anaesth (2013) 1.54
Huntington disease without CAG expansion: phenocopies or errors in assignment? Am J Hum Genet (1994) 1.53
No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457. Am J Psychiatry (2001) 1.49
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46
Firefly luciferase ATP assay as a screening method for bacteriuria. J Clin Microbiol (1983) 1.44
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Arch Gen Psychiatry (1990) 1.42
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry (1993) 1.41
Acrylamide: a cooking carcinogen? Chem Res Toxicol (2000) 1.40
A new polymorphic probe which defines the region of chromosome 19 containing the myotonic dystrophy locus. Am J Hum Genet (1990) 1.39
Preparation of a potential positron emission tomographic radioligand for the dopamine transporter. Eur J Nucl Med (1994) 1.38
Mutation screening in Rett syndrome patients. J Med Genet (2000) 1.38
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry (1988) 1.38
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology (1994) 1.38
Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol (1995) 1.33
Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem (1989) 1.31
DNA linkage analysis of X-linked retinoschisis. Hum Genet (1988) 1.31
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology (2004) 1.28
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun (2005) 1.28
Evidence for integrated EBV genomes in Raji cellular DNA. Nucleic Acids Res (1984) 1.27
Estimation of biomass in growing cell lines by adenosine triphosphate assay. Methods Enzymol (1986) 1.27
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res (1997) 1.26
Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding. J Cereb Blood Flow Metab (1998) 1.25
Imaging the living human brain: magnetic resonance imaging and positron emission tomography. Proc Natl Acad Sci U S A (1997) 1.22
Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab (1999) 1.22
Synthesis of L- and D-[methyl-11C]methionine. J Nucl Med (1987) 1.20
Enzymatic method for continuous monitoring of inorganic pyrophosphate synthesis. Anal Biochem (1985) 1.20
Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy. Neurology (2008) 1.20
Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes. Br J Cancer (1982) 1.18
Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med (1995) 1.18
Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia. Biol Psychiatry (2001) 1.18
Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res (1999) 1.17
A sensitive method for measuring ATP-formation in rat muscle mitochondria. Scand J Clin Lab Invest (1990) 1.17
Functional brain mapping of monkey tool use. Neuroimage (2001) 1.16
Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nucl Med Commun (2001) 1.16
NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet (2000) 1.16
Recombination events that locate myotonic dystrophy distal to APOC2 on 19q. Genomics (1989) 1.15
Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain (1997) 1.15
Road tunnel air pollution induces bronchoalveolar inflammation in healthy subjects. Eur Respir J (2007) 1.13
Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography. Acta Physiol Scand (1994) 1.13
Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease. Lancet (1997) 1.13
Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease. Hum Mol Genet (1995) 1.13
DNA polymorphisms within the porphobilinogen deaminase gene in two Swedish families with acute intermittent porphyria. Hum Genet (1988) 1.13
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol (1987) 1.13
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain (1997) 1.12
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain. Am J Psychiatry (2001) 1.11
Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat Genet (2001) 1.11
A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res (1998) 1.11
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis. Am J Hum Genet (1992) 1.10